Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer

NCT01261299 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

21

Enrollment

OTHER

Sponsor class

Stopped Contract ended

Conditions

Carcinoma, Non-Small-Cell Lung
Urinary Bladder Neoplasms

Interventions

DRUG: Carbon-14-labeled carboplatin

Sponsor

University of California, Davis

Collaborators

[object Object]
[object Object]